Article 1
Vitamin K2 (menaquinone) as a source of Vitamin K as specified in the Annex may be placed on the market in the Community as a novel food ingredient to be used in compliance with Directive 2001/15/EC and/or Regulation (EC) No 1925/2006.
2009/345/EC: Commission Decision of 22 April 2009 authorising the placing on the market of Vitamin K2 (menaquinone) from Bacillus subtilis natto as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document number C(2009) 2935)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Vitamin K2 (menaquinone) as a source of Vitamin K as specified in the Annex may be placed on the market in the Community as a novel food ingredient to be used in compliance with Directive 2001/15/EC and/or Regulation (EC) No 1925/2006.
The designation of the novel food ingredient authorised by this Decision on the labelling of the foodstuff containing it shall be ‘Menaquinone’ or ‘Vitamin K’.
This Decision is addressed to NattoParma, Dammensveien 40, PO Box 2896 Solli, N-0230 Oslo, Norway.
ANNEX Specifications of Vitamin K 2 (menaquinone) DESCRIPTION Vitamin K 2 (2-methyl-3- all-trans -polyprenyl-1,4-naphthoquinones), or the menaquinone series, is a group of prenylated naphthoquinone derivatives. The number of isoprene residues, where 1 isoprene unit consists of 5 carbons comprising the side chain, is used to characterise the menaquinone homologues. It is presented in an oil suspension that primarily contains MK-7, and MK-6 to a smaller extent. STRUCTURAL FORMULA Vitamin K (menaquinone) series with menaquinone-7 (MK-7)(n = 6) being C 46 H 64 O 2 , menaquinone-6 (MK-6)(n = 5) being C 41 H 56 O 2 and menaquinone-4 (MK-4)(n = 3) being C 31 H 40 O 2 .
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.